New daily pill aims to shed pounds in 12-Month obesity trial
NCT ID NCT06939296
First seen Apr 01, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study tests a new tablet called VCT220 to help overweight or obese adults lose weight. About 840 participants will take either a high dose, low dose, or placebo pill once daily for 12 months. The main goal is to see how much weight they lose and if it improves health markers like waist size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital （ There are multiple sites in this clinical trial）
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.